These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Targeted melanoma imaging and therapy with radiolabeled alpha-melanocyte stimulating hormone peptide analogues. Quinn T; Zhang X; Miao Y G Ital Dermatol Venereol; 2010 Apr; 145(2):245-58. PubMed ID: 20467398 [TBL] [Abstract][Full Text] [Related]
3. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression. Cheng Z; Xiong Z; Subbarayan M; Chen X; Gambhir SS Bioconjug Chem; 2007; 18(3):765-72. PubMed ID: 17348700 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749 [TBL] [Abstract][Full Text] [Related]
5. A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases. Froidevaux S; Calame-Christe M; Schuhmacher J; Tanner H; Saffrich R; Henze M; Eberle AN J Nucl Med; 2004 Jan; 45(1):116-23. PubMed ID: 14734683 [TBL] [Abstract][Full Text] [Related]
6. Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1. Ren G; Liu S; Liu H; Miao Z; Cheng Z Bioconjug Chem; 2010 Dec; 21(12):2355-60. PubMed ID: 21073170 [TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging and Radionuclide Therapy of Melanoma Targeting the Melanocortin 1 Receptor. Zhang C; Lin KS; Bénard F Mol Imaging; 2017; 16():1536012117737919. PubMed ID: 29182034 [TBL] [Abstract][Full Text] [Related]
8. Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. Hruby VJ; Lu D; Sharma SD; Castrucci AL; Kesterson RA; al-Obeidi FA; Hadley ME; Cone RD J Med Chem; 1995 Sep; 38(18):3454-61. PubMed ID: 7658432 [TBL] [Abstract][Full Text] [Related]
9. Melanoma Imaging Using Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486 [TBL] [Abstract][Full Text] [Related]
10. In Vivo evaluation of newly synthesized Kálmán-Szabó I; Képes Z; Fekete A; Vágner A; Nagy G; Szücs D; Gyuricza B; Arató V; Varga J; Kárpáti L; Garai I; Mándity I; Bruchertseifer F; Elek J; Szikra D; Trencsényi G J Pharm Biomed Anal; 2023 May; 229():115374. PubMed ID: 37001274 [TBL] [Abstract][Full Text] [Related]
11. Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH. Wei L; Zhang X; Gallazzi F; Miao Y; Jin X; Brechbiel MW; Xu H; Clifford T; Welch MJ; Lewis JS; Quinn TP Nucl Med Biol; 2009 May; 36(4):345-54. PubMed ID: 19423001 [TBL] [Abstract][Full Text] [Related]
12. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog. Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880 [TBL] [Abstract][Full Text] [Related]
13. Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution. Bapst JP; Calame M; Tanner H; Eberle AN Bioconjug Chem; 2009 May; 20(5):984-93. PubMed ID: 19388674 [TBL] [Abstract][Full Text] [Related]